Metraipolis › archive › dc_34574bbd1e5b

Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic — Europe PMC PMID:42329996

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42329996
DOI
10.1371/journal.pone.0351566
License (as archived)
solo-consultazione
Archived
2026-10-19T07:11:24.170Z
SHA-256 of the archived text
2915397365c79ad8eb11d424a42fe5ff12c0818854f20b34be8f35824bf1501a
Stable URL of this page
https://metraipolis.com/documento/dc_34574bbd1e5b

How to cite

Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic — Europe PMC PMID:42329996 — Europe PMC (en), https://europepmc.org/article/MED/42329996 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_34574bbd1e5b (Metraipolis archive dc_34574bbd1e5b, sha256 2915397365c79ad8eb11d424a42fe5ff12c0818854f20b34be8f35824bf1501a)
BibTeX
@misc{dc34574bbd1e5b,
  title = {Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic — Europe PMC PMID:42329996},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42329996},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_34574bbd1e5b; sha256 2915397365c79ad8eb11d424a42fe5ff12c0818854f20b34be8f35824bf1501a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42329996. Agents can read the archived copy with the MCP tool read_document.